Highly sensitive cardiac troponin T in heart failure: Comparison with echocardiographic parameters and natriuretic peptides

Journal of Cardiology

Volumn 59, Issue 2, 2012, Pages 202-208

  Kusumoto, Atsushi ^a   Miyata, Masaaki ^a   Kubozono, Takuro ^a   Ikeda, Yoshiyuki ^a   Shinsato, Takuro ^a   Kuwahata, So ^a   Fujita, Shoji ^a   Takasaki, Kunitsugu ^a   Yuasa, Toshinori ^a   Hamasaki, Shuichi ^a   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Cardiac dysfunction; Heart failure; Natriuretic peptides; Troponin T

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CREATININE; TROPONIN T;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; MALE; SEX DIFFERENCE;

AGED; BIOLOGICAL MARKERS; CREATININE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDES; REGRESSION ANALYSIS; TROPONIN T;

EID: 84857452173     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2011.11.012     Document Type: Article

References (32)

1. Ohman E.M., Armstrong P.W., Christenson R.H., Granger C.B., Katus H.A., Hamm C.W., O'Hanesian M.A., Wagner G.S., Kleiman N.S., Harrell F.E., Califf RM, Topol E.J. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996, 335:1333-1341.
2. Lindahl B., Toss H., Siegbahn A., Venge P., Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 2000, 343:1139-1147. for the FRISC Study Group.
3. Braunwald E., Antman E.M., Beasley J.W., Califf R.M., Cheitlin M.D., Hochman J.S., Jones R.H., Kereiakes D., Kupersmith J., Levin T.N., Pepine C.J., Schaeffer J.W., Smith E.E., Steward D.E., Theroux P. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 2000, 36:970-1062.
4. Aviles R.J., Askari A.T., Lindahl B., Wallentin L., Jia G., Ohman E.M., Mahaffey K.W., Newby L.K., Califf R.M., Simoons M.L., Topol E.J., Berger P., Lauer M.S. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 2002, 346:2047-2052.
5. Setsuta K., Seino Y., Takahashi N., Ogawa T., Sasaki K., Harada A., Takano T., Kishida H., Hayakawa H. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 1999, 84:608-611.
6. Sato Y., Yamada T., Taniguchi R., Nagai K., Makiyama T., Okada H., Kataoka K., Ito H., Matsumori A., Sasayama S., Takatsu Y. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 2001, 103:369-374.
7. Setsuta K., Seino Y., Ogawa T., Arao M., Miyatake Y., Takano T. Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure. Am J Med 2002, 113:717-722.
8. Sato Y., Taniguchi R., Makiyama T., Nagai K., Okada H., Yamada T., Matsumori A., Takatsu Y. Serum cardiac troponin T and plasma brain natriuretic peptide in patients with cardiac decompensation. Heart 2002, 88:647-648.
9. Ishii J., Nomura M., Nakamura Y., Naruse H., Mori Y., Ishikawa T., Ando T., Kurokawa H., Kondo T., Nagamura Y., Ezaki K., Hishida H. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 2002, 89:691-695.
10. Ishii J., Cui W., Kitagawa F., Kuno T., Nakamura Y., Naruse H., Mori Y., Ishikawa T., Nagamura Y., Kondo T., Oshima H., Nomura M., Ezaki K., Hishida H. Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure. Clin Chem 2003, 49:2020-2026.
11. Del Carlo C.H., Pereira-Barretto A.C., Cassaro-Strunz C., Latorre Mdo R., Ramires J.A. Serial measure of cardiac troponin T levels for prediction of clinical events in decompensated heart failure. J Card Fail 2004, 10:43-48.
12. Bertinchant J.P., Combes N., Polge A., Fabbro-peray P., Raczka F., Beck L., Cade S., Ledermann B. Prognostic value of cardiac troponin T in patients with both acute and chronic stable congestive heart failure: comparison with atrial natriuretic peptide, brain natriuretic peptide and plasma norepinephrine. Clin Chim Acta 2005, 352:143-153.
13. Latini R., Masson S., Anand I.S., Missov E., Carlson M., Vago T., Angelici L., Barlera S., Parrinello G., Maggioni A.P., Tognoni G., Cohn J.N. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007, 116:1242-1249. Val-HeFT Investigators.
14. Miller W.L., Hartman K.A., Burritt M.F., Grill D.E., Jaffe A.S. Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. J Am Coll Cardiol 2009, 54:1715-1721.
15. Kociol R.D., Pang P.S., Gheorghiade M., Fonarow G.C., O'Connor C.M., Felker G.M. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol 2010, 56:1071-1078.
16. Giannitsis E., Kurz K., Hallermayer K., Jarausch J., Jaffe A.S., Katus H.A. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010, 56:254-261.
17. Yamashita T., Seino Y., Ogawa A., Ogata K., Fukushima M., Tanaka K., Mizuno K. N-terminal pro-BNP is a novel biomarker for integrated cardio-renal burden and early risk stratification in patients admitted for cardiac emergency. J Cardiol 2010, 55:377-383.
18. Ono M., Tanabe K., Asanuma T., Yoshitomi H., Shimizu H., Ohta Y., Shimada T. Doppler echocardiography-derived index of myocardial performance (TEI index): comparison with brain natriuretic peptide levels in various heart disease. Jpn Circ J 2001, 65:637-642.
19. Mikkelsen K.V., Møller J.E., Bie P., Ryde H., Videbaek L., Haghfelt T. Tei index and neurohormonal activation in patients with incident heart failure: serial changes and prognostic value. Eur J Heart Fail 2006, 8:599-608.
20. Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol 1995, 26:135.
21. Tei C., Ling L.H., Hodge D.O., Bailey K.R., Oh J.K., Rodeheffer R.J., Tajik A.J., Seward J.B. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol 1995, 26:357-366.
22. Tei C., Nishimura R.A., Seward J.B., Tajik A.J. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr 1997, 10:169-178.
23. Nagueh S.F., Middleton K.J., Kopelen H.A., Zoghbi W.A., Quinones M.A. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997, 30:1527-1533.
24. Eggers K.M., Nygren M., Venge P., Jernberg T., Wikström B.G. High-sensitive troponin T and I are related to invasive hemodynamic data and mortality in patients with left-ventricular dysfunction and precapillary pulmonary hypertension. Clin Chim Acta 2011, 412:1582-1588.
25. Shah R.V., Chen-Tournoux A.A., Picard M.H., Januzzi J.L. Association between troponin T and impaired left ventricular relaxation in patients with acute decompensated heart failure with preserved systolic function. Eur J Echocardiogr 2009, 10:765-768.
26. Tsutamoto T., Kawahara C., Yamaji M., Nishiyama K., Fujii M., Yamamoto T., Horie M. Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure. Eur J Heart Fail 2009, 11:653-658.
27. Sato Y., Yamamoto E., Sawa T., Toda K., Hara T., Iwasaki T., Fujiwara H., Takatsu Y. High-sensitivity cardiac troponin T in essential hypertension. J Cardiol 2011, 58:226-231.
28. Masson S., Latini R., Anand I.S. An update on cardiac troponins as circulating biomarkers in heart failure. Curr Heart Fail Rep 2010, 7:15-21.
29. Miller W.L., Hartman K.A., Burritt M.F., Grill D.E., Rodeheffer R.J., Burnett J.C., Jaffe A.S. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation 2007, 116:249-257.
30. Narula J., Haider N., Virmani R., DiSalvo T.G., Kolodgie F.D., Hajjar R.J., Schmidt U., Semigran M.J., Dec G.W., Khaw B.-A. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996, 335:1182-1189.
31. Wencker D., Chandra M., Nguyen K., Miao W., Garantziotis S., Factor S.M., Shirani J., Armstrong R.C., Kitsis R.N. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 2003, 111:1497-1504.
32. Taniguchi R., Sato Y., Yamada T., Ooba M., Higuchi H., Matsumori A., Kimura T., Kita T. Combined measurements of cardiac troponin T and N-terminal pro-brain natriuretic peptide in patients with heart failure. Circ J 2004, 68:1160-1164.